This is the 5th year RFN has hosted the Top Nephrology Stories of the year poll. This is an attempt to look at the year in nephrology voted by the readers of RFN. Take a few moments and vote for any of the stories you feel are worthy of making the top 10 list. You can vote for as many as you wish. Write a quick blog post about a story you think deserves the vote. If we missed anything please feel free to comment below. Note, the story must be published after the year end poll of 2013.
Please go to the right hand side —–> of the RFN page and make your selection until Dec 12th. Results will be posted on Dec 25, 2014
Below contains links to each of the stories for more information.
JNC8 Hypertension Guidelines published in JAMA (this was published online after the poll last year)
ZS-9 trials for hyperkalemia in JAMA and NEJM (Nov 2014)
Patiromer OPAL-HK trial for hyperkalemia in NEJM (Nov 2014)
The PREDIAN Trial: pentoxifylline for diabetic kidney disease in JASN (June 2014)
SYMPLICITY-3 trial for renal denervation in resistant HTN in NEJM (March 2014)
Mesoamerican nephropathy continues to unfold
Dendritic cell isoketals activate T cells and promote HTN in JCI (October 2014)
Sustainable Growth Rate legislation in March 2014 pushed inclusion of oral only meds (phos binders) in ESRD out of bundle until 2024
α–Intercalated cells defend the urinary system from bacterial infection in JCI
Peritoneal dialysis solution shortage
IgA Nephropathy GWAS implicates genes involved in helminth immune response in Nature Genetics (Sept 2014)
Anti-Phospholipase A2 receptor assay licensed for commercial testing
Co-trimoxazole and sudden death in patients receiving RAS inhibitors in BMJ (Oct 2014)
Identification of thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy in NEJM (Nov 2014)
Perivascular Gli1+ progenitors contribute to myofibroblast pool leading to fibrosis in multiple organs including kidney Cell Stem Cell (Nov 2014)
HALT-PKD Trials of low BP target and ACEi/ARB combo in NEJM (Nov 2014)
CORONARY Trial of on-pump versus off-pump CABG and subsequent CKD (June 2014)
POSEIDEN Trial fluid administration guided by LV end diastolic pressure in Lancet (May 2014)
Gestational HTN or preeclampsia was more common in kidney donors in NEJM (Nov 2014)
Please go to the right hand side —–> of the RFN page and make your selection until Dec 12th. Results will be posted on Dec 25, 2014